Clinical Trial Update: A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis [Phase 1, Phase 2]

View source ↗

Summary

An early-stage study evaluating BBI-001 in healthy volunteers and patients with hereditary hemochromatosis across Phase 1 and Phase 2, not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemochromatosis

Drugs mentioned

• BBI-001

Snippet

Sponsor: Bond Biosciences | Conditions: Hereditary Hemochromatosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING